| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |